http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021325395-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd670cbd661b958be5910b97ac8cbffb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2016-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4db20c80233b501754a6606399de2d58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb4e59ab54384fbc54df46e5ebbb09af |
| publicationDate | 2021-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2021325395-A1 |
| titleOfInvention | Method, array and use thereof |
| abstract | The present invention relates to a method for determining the locality and/or presence of pancreatic cancer in an individual comprising or consisting of the steps of: (a) providing a sample to be tested from the individual, and (b) determining a biomarker signature of the test sample by measuring the expression in the test sample of one or more biomarkers selected from the group defined in Table A, wherein the expression in the test sample of one or more biomarkers selected from the group defined in Table A is indicative of the locality and/or presence of pancreatic cancer in the individual. The invention also comprises arrays and kits of parts for use in the method of the invention. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023102443-A3 |
| priorityDate | 2015-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1429.